2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy

Oct 11, 2019 8:00 AM

Today, more than 10,000 hematopoietic cell transplantations (HCTs) are performed yearly in the United States as treatment for more than 70 life threatening illnesses including cancers, genetic disorders, and other diseases. Also, given the shift toward cellular therapies in the field of HCT, the number of patients treated with these novel biologic agents is rapidly increasing. Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, this symposium will bring together experts and thought leaders from around the world in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT and cellular therapies, current advances in the field, and best practices to both prevent and treat these toxicities and symptoms.

MSK CME offers a 30% discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact cme@mskcc.org for more information.

Click here for more information and to register

cme_hematopoietic_cell_transplantation

2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy

Location:

Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
New York, NY 10065

Contact: